Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sugemule-4
- Development stage
- Unknown
- Lead developer
- Fourth People's Hospital of Ordos City
- Administration
- Oral
01
Overview
Sugemule-4 is a traditional Mongolian medicine (TMM) formulation primarily used for the treatment of insomnia, anxiety, and conditions characterized as heart-heat in Mongolian medical theory. It is typically composed of four main herbal ingredients: cardamom (Elettaria cardamomum), nutmeg (Myristica fragrans), chebulic myrobalan (Terminalia chebula), and sandalwood (Santalum album). The medicine is believed to regulate the Heyi (wind) element and soothe the mind. Clinical studies, such as those conducted by The Fourth People's Hospital of Ordos City, evaluate its efficacy in treating insomnia disorder compared to standard sedative-hypnotics or as a standalone therapy. It is traditionally administered as a powder or flavor powder.
- Other names
- Sugmel-4Sugmel4Sugmel 4Sugemule-4 flavorSugemule4 flavorSugemule 4 flavorSugemule-4 powderSugemule4 powderSugemule 4 powderSugmel-4 flavor powderSugmel4 flavor powderSugmel 4 flavor powder苏格木勒-4苏格木勒-4味散
02
Targets
DRD (Dopamine receptors)5-HT (Serotonin receptors)GluR (Glutamate receptors)
Beyond the preview
Go deeper on Sugemule-4.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sugemule-4.